Kimia Biosciences Limited (BOM:530313)
India · Delayed Price · Currency is INR 30.01
-0.98 (-3.16%)
At close: Jan 23, 2026
Kimia Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 81.81 | 96.12 | -53.09 | -93.52 | -37.03 | 51.04 | Upgrade |
Depreciation & Amortization | 35.83 | 33.6 | 32.44 | 32.73 | 28.96 | 18.74 | Upgrade |
Other Amortization | 0.19 | 0.19 | 0.49 | 0.6 | 0.45 | 0.36 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | -0.79 | -0.37 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | -0 | -0.03 | -0.02 | -0.41 | Upgrade |
Provision & Write-off of Bad Debts | - | - | - | 2.41 | - | - | Upgrade |
Other Operating Activities | 66.97 | 75.19 | 26.14 | 10.1 | 17.12 | 22.08 | Upgrade |
Change in Accounts Receivable | -29.52 | -101.36 | 39.15 | 10.81 | 92.51 | -53.47 | Upgrade |
Change in Inventory | -9.73 | -37.8 | 174.3 | -112.16 | -133.31 | -33.75 | Upgrade |
Change in Accounts Payable | -8.85 | 145.64 | -77.14 | 81.37 | 112.09 | 55.44 | Upgrade |
Change in Other Net Operating Assets | 0.67 | 1.56 | 3.06 | - | - | - | Upgrade |
Operating Cash Flow | 137.37 | 213.14 | 145.35 | -67.7 | 79.97 | 59.67 | Upgrade |
Operating Cash Flow Growth | - | 46.64% | - | - | 34.02% | 1834.20% | Upgrade |
Capital Expenditures | -56.76 | -45.99 | -15.07 | -28.12 | -35.8 | -135.61 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 20.67 | 0.5 | Upgrade |
Investment in Securities | - | - | 0.63 | - | - | 4 | Upgrade |
Other Investing Activities | -0.52 | -1.02 | -0.5 | 0.13 | 8.03 | -4.92 | Upgrade |
Investing Cash Flow | -57.28 | -47.01 | -14.93 | -27.99 | -7.1 | -136.03 | Upgrade |
Short-Term Debt Issued | - | 2.05 | - | 50.22 | - | 68.06 | Upgrade |
Long-Term Debt Issued | - | 54.04 | 13.4 | 170.42 | 123.43 | 166.56 | Upgrade |
Total Debt Issued | 115.38 | 56.08 | 13.4 | 220.63 | 123.43 | 234.62 | Upgrade |
Short-Term Debt Repaid | - | - | -0.92 | - | -15.58 | - | Upgrade |
Long-Term Debt Repaid | - | -164.43 | -107.66 | -97.6 | -150.99 | -129.93 | Upgrade |
Total Debt Repaid | -139.67 | -164.43 | -108.58 | -97.6 | -166.57 | -129.93 | Upgrade |
Net Debt Issued (Repaid) | -24.28 | -108.35 | -95.18 | 123.04 | -43.14 | 104.69 | Upgrade |
Other Financing Activities | -56.97 | -57.2 | -35.54 | -27.62 | -33.54 | -24.79 | Upgrade |
Financing Cash Flow | -81.25 | -165.55 | -130.72 | 95.41 | -76.68 | 79.91 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade |
Net Cash Flow | -1.16 | 0.59 | -0.3 | -0.27 | -3.82 | 3.55 | Upgrade |
Free Cash Flow | 80.61 | 167.15 | 130.28 | -95.82 | 44.17 | -75.94 | Upgrade |
Free Cash Flow Growth | - | 28.30% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 6.40% | 14.06% | 12.42% | -7.46% | 3.54% | -5.72% | Upgrade |
Free Cash Flow Per Share | 1.70 | 3.53 | 2.75 | -2.02 | 0.93 | -1.60 | Upgrade |
Cash Interest Paid | 56.97 | 57.2 | 35.54 | 27.62 | 33.54 | 24.79 | Upgrade |
Cash Income Tax Paid | - | -0.52 | -0.25 | -0.14 | 0.69 | -0.42 | Upgrade |
Levered Free Cash Flow | - | 54.08 | 114.12 | -67.59 | 56.5 | -147.11 | Upgrade |
Unlevered Free Cash Flow | - | 76.16 | 141.91 | -44.21 | 75.88 | -131.62 | Upgrade |
Change in Working Capital | -47.43 | 8.04 | 139.37 | -19.98 | 71.28 | -31.78 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.